drugset
Drugs / PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor
last change Dec 2025 re-read 3 minutes ago

PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor

Protein / enzyme biologic

Developed for
plasma cell myeloma
Investigated by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Wei Zhao · Yao Liu

Trials 2

today NCT06060080 · not/applicable NCT03844360 · Ph 4
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT03844360 Jan 2016 → Dec 2025 overdue hematopoietic and lymphoid cell neoplasm Wei Zhao Recruiting No outcome recorded
Phase not applicable1 trial
— NCT06060080 Apr 2022 → Dec 2023 plasma cell myeloma Yao Liu Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor ClinicalTrials.gov intervention name — accepted as the source's own label NCT03844360 ↗
1

NCT06060080 ↗
Modality Protein / enzyme biologic “pegylated recombinant human granulocyte-colony stimulating factor” NCT06060080 ↗